Prothena Corp Public (PRTA) Non-Current Assets (2012 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Non-Current Assets of $10.7 million in Q1 2026, down 7.91% quarter-over-quarter from $11.6 million in Q4 2025, and down 81.93% on a YoY basis from $59.2 million in Q1 2025.

Prothena Corp Public (PRTA) Non-Current Assets (2012 - 2026) Analysis & Trends

Prothena Corp Public's Non-Current Assets history runs 15 years deep, the most recent figure standing at $10.7 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 81.93% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (down 81.93% YoY), while the FY2025 annual figure was $11.6 million, down 81.18% from the prior year.
  • Non-Current Assets was $10.7 million for Q1 2026 at Prothena Corp Public, down from $11.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $61.7 million in Q4 2024 to a low of $10.7 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $39.3 million across 5 years, with a median of $41.2 million in 2023.
  • The sharpest annual moves came in 2023 and 2026: Non-Current Assets soared 88.49% in 2023, then plunged 81.93% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $38.9 million in 2022, then jumped by 46.65% to $57.1 million in 2023, then gained by 8.05% to $61.7 million in 2024, then tumbled by 81.18% to $11.6 million in 2025, then declined by 7.91% to $10.7 million in 2026.
  • The last three Non-Current Assets figures came in at $10.7 million (Q1 2026), $11.6 million (Q4 2025), and $12.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Prothena Corp Public 479.08 Mn 149.61 Mn - 10.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.69 Mn
Dec 31, 2025 11.61 Mn
Sep 30, 2025 12.65 Mn
Jun 30, 2025 13.59 Mn
Mar 31, 2025 59.16 Mn
Dec 31, 2024 61.70 Mn
Sep 30, 2024 60.27 Mn
Jun 30, 2024 59.59 Mn
Mar 31, 2024 57.33 Mn
Dec 31, 2023 57.10 Mn
Sep 30, 2023 56.32 Mn
Jun 30, 2023 43.55 Mn
Mar 31, 2023 41.24 Mn
Dec 31, 2022 38.94 Mn
Sep 30, 2022 29.88 Mn
Jun 30, 2022 28.30 Mn
Mar 31, 2022 25.79 Mn
Dec 31, 2021 24.56 Mn
Sep 30, 2021 25.17 Mn
Jun 30, 2021 26.91 Mn